Results 161 to 170 of about 26,266 (223)

Comparative histopathological and immunological analysis of LRV2-positive and LRV2-negative Leishmania tropica in a BALB/c mouse cutaneous leishmaniasis model. [PDF]

Parasitol Res
Öztatlıcı M, Öztatlıcı H, Arserim SK, Balcıoğlu IC.   +3 more
europepmc   +1 more source

Adrenergic signaling during parasitic infections. [PDF]

Front Immunol
Gardias P, Bąska P.
europepmc   +1 more source

ApoA1-driven cholesterol efflux and macrophage polarization orchestrate T-cell differentiation towards controlling Leishmania donovani pathogenesis. [PDF]

Sci Rep
Kumar V, Alti D, Kumari S, Ranjan R, Prasad D, Singh V, Sen A, Das P, Pandey K, Kumar A.   +9 more
europepmc   +1 more source

Immunomodulatory and regenerative effects of human umbilical cord MSC-EVs in Cutaneous Leishmaniasis. [PDF]

Stem Cell Res Ther
Borba PB, Torres CLM, da Costa MVM, Luz Y, da Silva KN, da Conceição Pires S, Loiola EC, Figueiredo JCQ, de Souza Santos L, Rocha GV, Menezes JPB, Costa-Ferro ZSM, de Freitas Souza BS, de Oliveira CI.   +13 more
europepmc   +1 more source

Modulation of fibroblast behavior by Leishmania: a pathway to understanding disease progression in cutaneous leishmaniasis. [PDF]

BMC Microbiol
de Queiroz Filho TN, Costa BF, Rodrigues APD.   +2 more
europepmc   +1 more source

Targeting macrophage phenotypes to prevent diseases caused by <i>Leishmania</i> and <i>Trypanosoma cruzi</i> infections. [PDF]

Front Immunol
Vellozo NS, Matos-Silva TC, Lopes MF.
europepmc   +1 more source

Non-additive strong gene interactions cause striking differences in organ pathology and cytokine response in Leishmaniasis. [PDF]

Front Immunol
Sohrabi Y, Kobets T, Volkova V, Javorková E, Krayem I, Zajícová A, Havelková H, Svobodová M, Holáň V, Demant P, Lipoldová M.   +10 more
europepmc   +1 more source

The Capsular Polysaccharides GXM and GXMGal from <i>Cryptococcus neoformans</i> Modulate Macrophages Infected with <i>Leishmania major</i>. [PDF]

Microorganisms
Ferreira-Dos-Santos IM, da Silva-Junior EB, Velez ASMM, Freire-de-Lima L, Morrot A, de Lima MEF, Makhoul GJ, Guimarães-de-Oliveira JC, Diniz-Lima I, Covre LP, Dos Santos RQ, Pepino FP, Abrantes LS, Pinto-da-Silva LH, Previato JO, Mendonça-Previato L, Freire-de-Lima CG, Decote-Ricardo D.   +17 more
europepmc   +1 more source

Risk factors for post-kala-azar dermal leishmaniasis (PKDL): Challenges in understanding pathophysiology. [PDF]

PLoS Negl Trop Dis
Zijlstra EE.
europepmc   +1 more source